Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

PubWeight™: 3.68‹?› | Rank: Top 1%

🔗 View Article (PMID 11525701)

Published in Arch Intern Med on September 10, 2001

Authors

P Bytzer1, N J Talley, M Leemon, L J Young, M P Jones, M Horowitz

Author Affiliations

1: Department of Medicine, University of Sydney, Nepean Hospital, Clinical Sciences Building, PO Box 63, Penrith, New South Wales 2751, Australia.

Associated clinical trials:

Gastrointestinal Motility Among Diabetes Patients | NCT02573519

Investigation of Eluxadoline for Diabetic Diarrhea | NCT04313088

Articles citing this

(truncated to the top 100)

Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int (2008) 2.39

A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol (2006) 2.10

Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum (2006) 2.01

The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77

Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut (2010) 1.63

A Practical Approach to Gastrointestinal Complications of Diabetes. Diabetes Ther (2016) 1.39

Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol (2008) 1.32

Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil (2010) 1.26

Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol (2011) 1.26

Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil (2012) 1.25

Oxidative stress: key player in gastrointestinal complications of diabetes. Neurogastroenterol Motil (2011) 1.25

Diabetes and the enteric nervous system. Neurogastroenterol Motil (2007) 1.19

Human pancreatic exocrine response to nutrients in health and disease. Gut (2005) 1.16

Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest (2006) 1.15

Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol (2009) 1.14

Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes. Diabetes (2013) 1.10

Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil (2014) 1.09

Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials. Diabetes Metab Syndr Obes (2012) 1.06

Factors affecting mobile diabetes monitoring adoption among physicians: questionnaire study and path model. J Med Internet Res (2012) 1.05

The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus. Korean J Intern Med (2009) 1.04

Gastroparesis--current concepts and considerations. Medscape J Med (2008) 1.04

Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis. World J Gastroenterol (2015) 1.01

Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci (2006) 1.01

Recent advances in the pathophysiology and treatment of gastroparesis. J Neurogastroenterol Motil (2013) 1.01

Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study. J Gen Intern Med (2012) 1.00

Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. J Neurogastroenterol Motil (2010) 0.98

Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil (2012) 0.98

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J (2016) 0.96

Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J (2016) 0.95

Enteric neuropathy can be induced by high fat diet in vivo and palmitic acid exposure in vitro. PLoS One (2013) 0.94

Risk factors in acquired faecal incontinence. J R Soc Med (2004) 0.93

Association of diabetes and HbA1c levels with gastrointestinal manifestations. Diabetes Care (2012) 0.93

New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol (2013) 0.92

High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes. Cell Tissue Res (2013) 0.92

Alterations of colonic contractility in long-term diabetic rat model. J Neurogastroenterol Motil (2011) 0.92

Stomach bugs and diabetes: an astounding observation or just confounding? Diabetes Care (2012) 0.92

Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice. Int J Exp Pathol (2011) 0.91

Diabetes-related alterations in the enteric nervous system and its microenvironment. World J Diabetes (2012) 0.89

What are the important subsets of gastroparesis? Neurogastroenterol Motil (2012) 0.89

Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol (2010) 0.89

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients. Diabetes Metab Syndr Obes (2015) 0.88

Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol (2010) 0.88

Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. Diabetes Care (2013) 0.87

2, 3, 5, 4'-Tetrahydroxystilbene-2-O-beta-D-glucoside improves gastrointestinal motility disorders in STZ-induced diabetic mice. PLoS One (2012) 0.86

L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats. Dig Dis Sci (2011) 0.85

Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud (2011) 0.84

Epidemiology and natural history of gastroparesis. Gastroenterol Clin North Am (2014) 0.84

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland. Diabetes Metab Syndr Obes (2014) 0.83

Assessment of the length of myotomy in peroral endoscopic pyloromyotomy (G-POEM) using a submucosal tunnel technique (video). Surg Endosc (2014) 0.83

Effect of apple cider vinegar on delayed gastric emptying in patients with type 1 diabetes mellitus: a pilot study. BMC Gastroenterol (2007) 0.83

Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice. Am J Physiol Gastrointest Liver Physiol (2011) 0.83

Diabetic gastroparesis: Therapeutic options. Diabetes Ther (2010) 0.82

Meta-analysis of acupuncture for relieving non-organic dyspeptic symptoms suggestive of diabetic gastroparesis. BMC Complement Altern Med (2013) 0.82

The effect of autonomous neuropathy on bowel preparation in type 2 diabetes mellitus. Int J Colorectal Dis (2009) 0.81

Diabetes induces GABA receptor plasticity in murine vagal motor neurons. J Neurophysiol (2015) 0.81

Effect of endogenous insulin-like growth factor and stem cell factor on diabetic colonic dysmotility. World J Gastroenterol (2013) 0.81

Gastrointestinal signs and symptoms among persons with diabetes mellitus. Gastroenterol Hepatol Bed Bench (2011) 0.80

Diabetic neuropathy: an evaluation of the use of quercetin in the cecum of rats. World J Gastroenterol (2013) 0.80

Sensory neuromodulators in functional nausea and vomiting: predictors of response. Postgrad Med J (2012) 0.80

Neuroprotective effect of quercetin on the duodenum enteric nervous system of streptozotocin-induced diabetic rats. Dig Dis Sci (2012) 0.79

An inherent acceleratory effect of insulin on small intestinal transit and its pharmacological characterization in normal mice. World J Gastroenterol (2006) 0.79

Prevalence of gastrointestinal symptoms in patients with type 2 diabetes: a population-based study. Arch Intern Med (2002) 0.78

Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology. J Diabetes Sci Technol (2010) 0.78

The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss. Purinergic Signal (2014) 0.78

Faecal incontinence: Current knowledges and perspectives. World J Gastrointest Pathophysiol (2016) 0.78

Prevalence of Gastroesophageal Reflux Disease in Type II Diabetes Mellitus. Gastroenterol Res Pract (2014) 0.78

Effect of duodenal glucose and acute hyperglycemia on rectal perception and compliance in response to tension-controlled rectal distension in healthy humans. Dig Dis Sci (2008) 0.77

Vulnerability of Gastric Mucosa in Diabetic Rats, Its Pathogenesis and Amelioration by Cuminum cyminum. Indian J Pharm Sci (2012) 0.77

The important roles of interstitial cells of cajal and cholinergic receptors on diabetes related dysfunction of colon. J Neurogastroenterol Motil (2011) 0.77

Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review. World J Gastroenterol (2014) 0.77

Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One (2014) 0.77

Effects of insulin treatment on HuC/HuD, NADH diaphorase, and nNOS-positive myoenteric neurons of the duodenum of adult rats with acute diabetes. Dig Dis Sci (2008) 0.76

Impact of myenteric plexus alterations on diabetes related gastrointestinal dysmotility. J Neurogastroenterol Motil (2013) 0.76

Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum. Cell Tissue Res (2015) 0.76

Gastric nNOS reduction accompanied by natriuretic peptides signaling pathway upregulation in diabetic mice. World J Gastroenterol (2014) 0.76

Rectal sensitivity in diabetes patients with symptoms of gastroparesis. J Diabetes Res (2014) 0.76

Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice. World J Gastrointest Pharmacol Ther (2013) 0.76

Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc (2015) 0.76

Neuroenteric Stimulation for Gastroparesis. Curr Treat Options Gastroenterol (2015) 0.76

Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes (2017) 0.76

Characterization of smooth muscle, enteric nerve, interstitial cells of Cajal, and fibroblast-like cells in the gastric musculature of patients with diabetes mellitus. World J Gastroenterol (2016) 0.75

Case report--the 46 year old man with a 5 month history of vomiting. Malawi Med J (2011) 0.75

Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors. World J Gastroenterol (2016) 0.75

Origins of Western diseases. J R Soc Med (2011) 0.75

Computer aided classification of cell nuclei in the gastrointestinal tract by volume and principal axis. Proc SPIE Int Soc Opt Eng (2007) 0.75

Electroacupuncture combined with mosapride alleviates symptoms in diabetic patients with gastroparesis. Exp Ther Med (2017) 0.75

Ischemic colitis of the left colon in a diabetic patient. Case Rep Gastroenterol (2011) 0.75

Dysphagia after vertical sleeve gastrectomy: Evaluation of risk factors and assessment of endoscopic intervention. World J Gastroenterol (2016) 0.75

Nutritional therapy for the management of diabetic gastroparesis: clinical review. Diabetes Metab Syndr Obes (2012) 0.75

Self-Reported Gastrointestinal Symptoms in Type 2 Diabetes Improve With an Intensive Lifestyle Intervention: Results From the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Clin Diabetes (2015) 0.75

Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7). Diabetes Metab J (2016) 0.75

Brain changes in diabetes mellitus patients with gastrointestinal symptoms. World J Diabetes (2016) 0.75

Risk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trials. Drug Des Devel Ther (2014) 0.75

Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7). Diabetes Metab J (2016) 0.75

Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods. PLoS One (2015) 0.75

Chinese herbal medicine banxiaxiexin decoction treating diabetic gastroparesis: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2013) 0.75

The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients. J Neurogastroenterol Motil (2016) 0.75

Specific inhibition of bile acid transport alters plasma lipids and GLP-1. BMC Cardiovasc Disord (2015) 0.75

Diabetes Mellitus and the Colon. Curr Treat Options Gastroenterol (2017) 0.75

Management of chronic constipation in adults. United European Gastroenterol J (2016) 0.75

Articles by these authors

Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Novel mechanism for RNA maturation: the leader sequences of simian virus 40 mRNA are not transcribed adjacent to the coding sequences. Proc Natl Acad Sci U S A (1977) 4.64

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62

Social amnesia in mice lacking the oxytocin gene. Nat Genet (2000) 4.52

The neurobiology of attachment. Nat Rev Neurosci (2001) 4.22

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81

Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci (2001) 3.40

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet (1995) 3.35

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00

Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res (2001) 2.97

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87

Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. Gut (1983) 2.83

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82

Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73

Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69

Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60

Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52

The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med (1996) 2.40

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38

Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A (1999) 2.32

Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A (1996) 2.31

Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28

Explicit intraoperative recall at a Bispectral Index of 47. Anesth Analg (2001) 2.27

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22

Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci U S A (1988) 2.22

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17

Topical pharyngeal anesthesia does not improve upper gastrointestinal endoscopy in conscious sedated patients. Am J Gastroenterol (1999) 2.15

Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut (2008) 2.13

Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med (1994) 2.13

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05

Allogeneic blood stem cell transplantation: considerations for donors. Blood (1997) 2.03

Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. Stroke (1991) 2.03

The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01

Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98

Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women's Health Study. Epidemiology (2001) 1.96

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.95

CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol (1998) 1.93

Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol (1988) 1.89

Circumcision: successful glanular reconstruction and survival following traumatic amputation. J Urol (1996) 1.88

Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85

Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol (1989) 1.85

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84

Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84

Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry (2008) 1.82

Naturally occurring differences in maternal care are associated with the expression of oxytocin and vasopressin (V1a) receptors: gender differences. J Neuroendocrinol (2002) 1.81

Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81

Characterization of the oxytocin system regulating affiliative behavior in female prairie voles. Neuroscience (2009) 1.80

Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci (2000) 1.78

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology (1997) 1.77

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76

Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76

Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med (1999) 1.76

Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75

Natural history of diabetic gastroparesis. Diabetes Care (1999) 1.74

The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol (1999) 1.73

Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J Neurosci (2001) 1.71

Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry (2002) 1.70

Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70

Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology (1986) 1.69

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68

Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68

Vasopressin-dependent neural circuits underlying pair bond formation in the monogamous prairie vole. Neuroscience (2004) 1.67

Expression of chimeric genes in the early region of SV40. J Mol Appl Genet (1983) 1.65

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther (2014) 1.64

Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64

The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64

Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust (2000) 1.63

Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol (1999) 1.63

Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62

Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J Biol Chem (2001) 1.61